EVPL and ENTPD3 are significantly involved in immunological pathways and are closely associated with the aberrant immune landscapes and altered immune responses of the two diseases, highlighting the importance of focusing on immunological mechanisms in the comorbidity of T2DM and CRC. The gene discussed is ENTPD3; the disease is colorectal carcinoma.